M&A Deal Summary |
|
|---|---|
| Date | 2023-02-28 |
| Target | Amplexor Life Sciences |
| Sector | Software |
| Buyer(s) | ArisGlobal |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1987 |
| Sector | Internet Software and Services |
| Employees | 1,495 |
ArisGlobal provides cloud-based life-sciences software that streamlines drug development, safety, regulatory, and medical affairs operations. Its AI-powered LifeSphere® platform helps pharma, biotech, and CROs automate compliance, streamline R&D operations, and accelerate the development of safer, more effective therapies. ArisGlobal was founded in 1987 and is based in Waltham, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Software M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| Country: Slovenia M&A | 1 of 1 |
| Year: 2023 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-05-11 |
Boehringer Ingelheim s Benefit-Risk Analytic System
Ingelheim am Rhein, Germany Boehringer Ingelheim's Benefit-Risk Analytic System (BRASS) is a software solution designed to support causal analysis of drug safety data in a highly regulated environment. |
Buy | - |
